TrustCore Financial Services’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

TrustCore Financial Services’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,540	Closed	-$10K	–	1189
2021 Q2	$10K	Hold	1,540	–	–	﹤0.01%	751
2021 Q1	$11K	Hold	1,540	–	–	﹤0.01%	685
2020 Q4	$9K	Hold	1,540	–	–	﹤0.01%	709
2020 Q3	$9K	Hold	1,540	–	–	﹤0.01%	629
2020 Q2	$8K	Hold	1,540	–	–	﹤0.01%	664
2020 Q1	$6K	Hold	1,540	–	–	﹤0.01%	677
2019 Q4	$10K	Hold	1,540	–	–	﹤0.01%	652
2019 Q3	$13K	Buy	1,540 +950	+161%	+$7.07K	﹤0.01%	602
2019 Q2	$4K	Hold	590	–	–	﹤0.01%	789
2019 Q1	$5K	Hold	590	–	–	﹤0.01%	686
2018 Q4	$9K	Sell	590 -25	-4%	-$550	0.01%	296
2018 Q3	$20K	Buy	+615	New	+$15.8K	0.01%	454

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TrustCore Financial Services's AVEO Position: Q3 2021 in Review

TrustCore Financial Services sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2021, closing a stake of 1,540 shares — an estimated $10K sold.

TrustCore Financial Services first reported a position in AVEO in Q3 2018 and held it in 12 quarters. The position peaked at $20K in Q3 2018. 52 funds tracked by Wall St. Rank hold AVEO as of Q3 2021.

TrustCore Financial Services reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
TrustCore Financial Services sold 1,540 AVEO Pharmaceuticals, Inc. shares in Q3 2021, an estimated $10K.
TrustCore Financial Services first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2018 and held it in 12 quarters.
TrustCore Financial Services's AVEO Pharmaceuticals, Inc. position peaked at $20K in Q3 2018.
52 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2021.

Based on TrustCore Financial Services's 13F filing for Q3 2021, filed 8 Nov 2021.